SMEs

Welcron Company Limited Posts First-Half Operating Profit of 2.8 Billion, 'Returns to Profitability'… Profitability Rises in Living and Defense Sectors

First-Half Revenue of 131.1 Billion, Net Income of 14.1 Billion Expanding Bedding Product Line and Targeting Overseas Defense Markets

KIM EUNG-TAE
2026-08-14 14:25:43
[Edaily Reporter KIM EUNG-TAE ] Welcron Company Limited(065950)announced on the 14th that it posted an operating profit of 2.8 billion won on a consolidated basis for the first half of this year, marking a return to profitability compared to the previous year.
Revenue for the same period totaled 131.1 billion won, a 5.2% decrease from the previous year. Net income was 14.1 billion won, marking a return to profitability compared to the previous year.
The Welcron Company Limited’s return to profitability in the first half of this year is attributed to steady improvements in profitability across its functional fiber and defense materials businesses. The Welcron Company Limited official stated, “Despite significant volatility in the external environment, we recorded a stable profit through product competitiveness and cost innovation in our core businesses of functional fibers and defense materials,” adding, “In the second half of the year, we will further boost profitability by strengthening our premium bedding lineup and pursuing aggressive sales in overseas defense markets.”
Welcron Company Limited’s headquarters in Guro-gu, Seoul. (Photo: Welcron Company Limited)

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

"Baek Jong-won Risk" Eases… The BORN Korea Narrows Third-Quarter Loss

As the controversy surrounding Baek Jong-won, CEO of The BORN Korea, begins to subside, the company’s net loss for the third quarter of this year has narrowed significantly. The quarterly operating lo…
2026-11-13 18:23:44

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02